PharmEnable
Biotech · Cambridge, GB
Drug-discovery company developing small-molecule drugs for oncology and neurology.
Funding history
| Date | Round | Amount |
|---|
| May 2023 | Funding round Cambridge biotech PharmEnable raised $7.5M pre-Series A led by MP Healthcare Venture Management. | $7.5M |
Investors
Cambridge EnterpriseMP Healthcare Venture Managemento2h Ventures
Similar companies in Biotech
Explore funding flow on EquityFlow →